BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 60502)

  • 21. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of type specific IgG Pseudomonas antibodies by the ELISA test after administration of the anti Pseudomonas aeruginosa vaccine.
    Meitert T; Meitert E; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(1):53-60. PubMed ID: 6442132
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of the specific activity of hyperimmune anti-Pseudomonas aeruginosa human plasma in an experiment].
    Podgornaia LG; Shinkarenko AA; Krokhina MA; Dziuban NF; D'iachenko VF
    Patol Fiziol Eksp Ter; 1987; (2):70-2. PubMed ID: 3112715
    [No Abstract]   [Full Text] [Related]  

  • 24. IgE antibody production to exoenzymes and common antigen (OEP) of Pseudomonas aeruginosa in mice.
    Cho YJ; Oh YH; Abe C; Homma JY; Usui M; Matuhasi T
    Jpn J Exp Med; 1978 Dec; 48(6):491-6. PubMed ID: 108438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of the amplified enzyme-linked immunosorbent assay: comparative quantitation of bovine serum IgG1, IgG2, IgA, and IgM antibodies.
    Butler JE; McGivern PL; Cantarero LA; Peterson L
    Am J Vet Res; 1980 Sep; 41(9):1479-91. PubMed ID: 7004283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Enzyme-linked immunosorbent assay (ELISA) for IgG- and IgM antibodies in chlamydial infections of humans].
    Schmeer N; Arens M; Krauss H; Schiefer HG; Weidner W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Nov; 256(1):119-31. PubMed ID: 6362279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local IgA and IgG response to intratracheal immunization with Pseudomonas aeruginosa antigens.
    Johansen HK; Høiby N
    APMIS; 1992 Jan; 100(1):87-90. PubMed ID: 1536724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of immunofluorescent antibody test and enzyme-linked immunosorbent assay for detection of antibodies to Listeria monocytogenes.
    Russell EG
    Acta Microbiol Hung; 1989; 36(2-3):309-13. PubMed ID: 2517177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis.
    Van Bever HP; Gigase PL; De Clerck LS; Bridts CH; Franckx H; Stevens WJ
    Arch Dis Child; 1988 Oct; 63(10):1222-8. PubMed ID: 3143315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Passive protective properties of serum fractions from mice inoculated with an anti-pseudomonas vaccine.
    Jones RJ; Hall M; Ricketts CR
    Immunology; 1972 Dec; 23(6):889-95. PubMed ID: 4630781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.
    Lieberman MM; McKissock DC; Wright GL
    Infect Immun; 1979 Feb; 23(2):509-21. PubMed ID: 106013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa.
    Penketh AR; Pitt TL; Hodson ME; Batten JC
    J Med Microbiol; 1983 Nov; 16(4):401-8. PubMed ID: 6417338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of antibody in infections due to Pseudomonas aeruginosa.
    Young LS
    J Infect Dis; 1974 Nov; 130 Suppl(0):S111-8. PubMed ID: 4213568
    [No Abstract]   [Full Text] [Related]  

  • 34. Antigenic relationship between the common antigen (OEP) of Pseudomonas aeruginosa and Vibrio cholerae.
    Hirao Y; Homma JY
    Infect Immun; 1978 Feb; 19(2):373-7. PubMed ID: 75846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibody titer of the serum of patients with Pseudomonas aeruginosa infection. Passive hemagglutination test using original endotoxin protein(OEP)].
    Saku K
    Kansenshogaku Zasshi; 1975 Sep; 49(9):358-63. PubMed ID: 814177
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection.
    Preston MJ; Berk JM; Hazlett LD; Berk RS
    Infect Immun; 1991 Jun; 59(6):1984-90. PubMed ID: 1903770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pseudomonas infections in a hospital. 4. Type specific antibody in human serum].
    Shigeta S; Yasunaga Y
    Nihon Saikingaku Zasshi; 1976 Sep; 31(5):621-8. PubMed ID: 826672
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum IgG, IgA and IgM changes during infectious complications induced by facultative pathogenic gram-negative bacteria.
    Petrás G; Merétey K
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):96-105. PubMed ID: 44628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies.
    Bjornson AB; Michael JG
    Infect Immun; 1972 May; 5(5):775-82. PubMed ID: 4629252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzyme-linked immunosorbent assay antibody responses to a temperature-sensitive mutant of Pseudomonas aeruginosa.
    Sordelli DO; Rojas RA; Cerquetti MC; Hooke AM; Degnan PJ; Bellanti JA
    Infect Immun; 1985 Oct; 50(1):324-7. PubMed ID: 3930404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.